---
actionable_items:
- action: potentially
  category: investigation
  full_context: 'we could potentially '
  priority: medium
companies:
- category: unknown
  confidence: medium
  context: Welcome everyone to the AI and Business Podcast. I'm Matthew Damello, Editorial
    Director here at
  name: Business Podcast
  position: 31
- category: unknown
  confidence: medium
  context: come everyone to the AI and Business Podcast. I'm Matthew Damello, Editorial
    Director here at Emerge AI Research. T
  name: Matthew Damello
  position: 53
- category: unknown
  confidence: medium
  context: the AI and Business Podcast. I'm Matthew Damello, Editorial Director here
    at Emerge AI Research. Today's guest is Jung
  name: Editorial Director
  position: 70
- category: unknown
  confidence: medium
  context: . I'm Matthew Damello, Editorial Director here at Emerge AI Research. Today's
    guest is Jung Liu, Director of Data Scie
  name: Emerge AI Research
  position: 97
- category: unknown
  confidence: medium
  context: ctor here at Emerge AI Research. Today's guest is Jung Liu, Director of
    Data Science in AI at Novartis. Jung
  name: Jung Liu
  position: 134
- category: unknown
  confidence: medium
  context: Research. Today's guest is Jung Liu, Director of Data Science in AI at
    Novartis. Jung joins us on today's show
  name: Data Science
  position: 156
- category: unknown
  confidence: medium
  context: ecutive thought leaders, everyone from the CIO of Goldman Sachs to the
    head of AI at Raytheon and AI pioneers lik
  name: Goldman Sachs
  position: 1332
- category: unknown
  confidence: medium
  context: o the head of AI at Raytheon and AI pioneers like Yasha Wabengio. With
    nearly a million annual listeners, AI and B
  name: Yasha Wabengio
  position: 1397
- category: unknown
  confidence: medium
  context: eve you can help other leaders move the needle on AI ROI, visit Emerge.com
    and fill out our Thought Leader
  name: AI ROI
  position: 1865
- category: unknown
  confidence: medium
  context: edle on AI ROI, visit Emerge.com and fill out our Thought Leaders submission
    form. That's Emerge.com and click on b
  name: Thought Leaders
  position: 1907
- category: unknown
  confidence: medium
  context: ne. Again, that's emerj.com/expertone. Hey folks, Steven Johnson here,
    co-founder of Notebook LM. As an author, I'
  name: Steven Johnson
  position: 2159
- category: unknown
  confidence: medium
  context: ne. Hey folks, Steven Johnson here, co-founder of Notebook LM. As an author,
    I've always been obsessed with how
  name: Notebook LM
  position: 2194
- category: tech
  confidence: high
  context: and helping you brainstorm. Try it at notebooklm.google.com. Without further
    ado, here's our conversation
  name: Google
  position: 2559
- category: unknown
  confidence: medium
  context: Without further ado, here's our conversation with Zhong Liu. Dr. Liu, thank
    you so much for being with us onc
  name: Zhong Liu
  position: 2621
- category: unknown
  confidence: medium
  context: many, many different aspects, R&D in healthcare. If I can jump in just
    right there very quickly, just t
  name: If I
  position: 5301
- category: unknown
  confidence: medium
  context: lking about generic AI versus the domain-specific Gen AI. When we delve
    into those domain-specific use cas
  name: Gen AI
  position: 7024
- category: unknown
  confidence: medium
  context: sults, you know, as for the healthcare companies. So I think it's a combination,
    it's a hybrid method, r
  name: So I
  position: 17987
- category: unknown
  confidence: medium
  context: s to have some awareness of this history as well. And I think this episode
    and everything we've described
  name: And I
  position: 24107
- category: ai_media_and_analysis
  confidence: high
  context: The organization hosting the 'AI and Business Podcast' and featuring executive
    thought leaders on AI adoption.
  name: Emerge AI Research
  source: llm_enhanced
- category: ai_user_enterprise
  confidence: high
  context: Jung Liu's employer, a company in the life sciences sector actively exploring
    and implementing generative AI and LLMs in R&D and clinical workflows.
  name: Novartis
  source: llm_enhanced
- category: ai_user_enterprise
  confidence: medium
  context: Mentioned as an example of a company whose CIO has been featured on the
    podcast, indicating their involvement in enterprise AI strategy.
  name: Goldman Sachs
  source: llm_enhanced
- category: ai_user_enterprise
  confidence: medium
  context: Mentioned as an example of a company whose head of AI has been featured
    on the podcast, indicating their involvement in enterprise AI strategy.
  name: Raytheon
  source: llm_enhanced
- category: ai_application
  confidence: high
  context: An AI-first tool for organizing ideas and making connections, built by
    Steven Johnson, focused on document analysis and brainstorming.
  name: Notebook LM
  source: llm_enhanced
- category: ai_infrastructure
  confidence: high
  context: Credited with proposing the transformer architecture, which is foundational
    to modern LLMs and GenAI.
  name: Google
  source: llm_enhanced
- category: ai_application
  confidence: high
  context: The specific URL provided for the Notebook LM tool, confirming its association
    with Google.
  name: NotebookLM.google.com
  source: llm_enhanced
- category: consulting_with_ai_focus
  confidence: high
  context: Mentioned as the source of a survey regarding life sciences leaders' investment
    in generative AI initiatives.
  name: Deloitte
  source: llm_enhanced
- category: ai_model_developer
  confidence: medium
  context: The term 'chat GPT' is used, strongly implying the technology developed
    by OpenAI, which spurred the current LLM explosion.
  name: OpenAI (Implied via GPT)
  source: llm_enhanced
- category: ai_model_architecture
  confidence: high
  context: Mentioned as a specific type of transformer architecture leveraged for
    generating new sequences (like language or molecules).
  name: GPT
  source: llm_enhanced
- category: ai_application
  confidence: low
  context: Implied as the originator/primary developer of GPT technology, though the
    company name itself is not explicitly stated.
  name: OpenAI
  source: llm_enhanced
- category: general_industry_reference
  confidence: high
  context: General reference to organizations providing open public architectures
    for leveraging AI.
  name: Tech companies
  source: llm_enhanced
date: 2025-10-21 06:00:00 +0000
duration: 31
has_transcript: false
insights:
- actionable: true
  confidence: medium
  extracted: align, you know, between different parties, like scientists, basic scientists,
    or AI modelers, AI professionals, and also leadership teams, AI adoption, etc
  text: we should align, you know, between different parties, like scientists, basic
    scientists, or AI modelers, AI professionals, and also leadership teams, AI adoption,
    etc.
  type: recommendation
layout: episode
llm_enhanced: true
original_url: https://traffic.libsyn.com/secure/techemergence/Business_-_10.21.25_-_Xiong_Liu.mp3?dest-id=151434
processing_date: 2025-10-21 15:08:40 +0000
quotes:
- length: 205
  relevance_score: 8
  text: So you can use this kind of advanced embedding-like features to improve the
    prediction accuracy of your machine learning but now the GPT they also leverage
    the decoding part of the transformer architecture
  topics: []
- length: 244
  relevance_score: 6
  text: So we have witnessed from the early years the machine learning technologies,
    by the supervised learning, unsupervised learning, and then we move to the deep
    learning techniques like convolutional neural networks, RNNs, and graph neural
    networks
  topics: []
- length: 238
  relevance_score: 6
  text: So the benefit is that even if you have very small data for your own machine
    learning tasks, you can leverage those foundation models because they already
    capture some relevant information, although it may not be specifically to your
    data
  topics: []
- length: 156
  relevance_score: 4
  text: Jung joins us on today's show to explore how generative AI and large language
    models are revolutionizing R&D and clinical workflows throughout life sciences
  topics: []
- length: 289
  relevance_score: 4
  text: Together, we break down the shift from traditional task-based machine learning
    to foundational models that leverage massive data repositories, enabling teams
    to accelerate molecule design, digital twin creation, and protocol optimization
    through deeper automation and improved data quality
  topics: []
- length: 238
  relevance_score: 4
  text: Our conversation also highlights practical challenges in workflow, including
    building domain-specific benchmarks, enabling tighter alignment between scientists
    and AI teams, and adopting new evaluation standards for AI-driven research ROI
  topics:
  - valuation
- length: 152
  relevance_score: 4
  text: But first, are you driving AI transformation at your organization, or maybe
    you're guiding critical decisions on AI investments, strategy, or deployment
  topics:
  - investment
- length: 134
  relevance_score: 4
  text: Obviously, this is a developing story from even a few years ago where we saw
    the explosion of LLMs and generative AI across industries
  topics: []
- length: 233
  relevance_score: 4
  text: So the difference is that previously when we do machine learning, we just
    collect our own data, we label the data, and then apply algorithms to train models
    so that we can get a working model to predict the outputs for the new inputs
  topics: []
- length: 99
  relevance_score: 4
  text: But now people have been developing these new paradigms, which is along with
    LLMs foundation models
  topics: []
- length: 159
  relevance_score: 4
  text: So we are familiar with LLMs, they trained based on all the human corpus,
    all the human languages you can imagine, all field of settings, large language
    models
  topics: []
- length: 101
  relevance_score: 4
  text: Fine-tuning meaning yes, we take the foundation models but we can still take
    the data you have, right
  topics: []
- length: 95
  relevance_score: 4
  text: It doesn't mean we retrain the whole, you know, the foundation model, large
    language model, etc
  topics: []
- length: 219
  relevance_score: 4
  text: Maybe we can give some more detailed examples about how GenAI and the foundation
    models work and then we can delve into, you know, the development, right, how
    we build up and, you know, put those models into work, right
  topics: []
- length: 229
  relevance_score: 4
  text: I just give some examples about using foundation models, GenAI to generate
    new cell types and gene expressions so that we can do all kinds of in silico,
    you know, treatment methods to see, to observe the predicted phenotypes, etc
  topics: []
- length: 142
  relevance_score: 4
  text: They could all fit into those kind of transformer architecture to let you
    learn the hidden embedding signatures of those molecules, atoms, etc
  topics: []
- length: 283
  relevance_score: 4
  text: And then this text knowledge about not just AI, computer science, but also
    the knowledge about the data themselves, although the goal of the foundation model
    is, it's tried to, you know, leverage all the available data, minimizing, you
    know, the specifics, you know, of specific data
  topics: []
- length: 152
  relevance_score: 4
  text: And we see this built in, it's an advantage that natural language processing
    as a domain became one of the first gigantic generative AI use cases, right
  topics: []
- length: 70
  relevance_score: 3
  text: So we can use the data you have to train to fine-tune the model, right
  topics: []
- length: 105
  relevance_score: 3
  text: So that is based on the breakthrough of the transformer architecture that
    Google proposed a long time ago
  topics: []
- impact_reason: Clearly defines the fundamental shift from traditional task-specific
    ML (requiring labeled data) to the foundation model paradigm.
  relevance_score: 10
  source: llm_enhanced
  text: The difference is that previously when we do machine learning, we just collect
    our own data, we label the data, and then apply algorithms to train models...
    But now people have been developing these new paradigms, which is along with LLMs
    foundation models.
  topic: technical
- impact_reason: 'Explains the core concept of foundation models: leveraging massive,
    diverse data (even ''irrelevant'' data within the domain) for pre-training.'
  relevance_score: 10
  source: llm_enhanced
  text: The idea is that yes, you still care about the specific data you are working
    on, but at the same time, we want to collect all the available data, relevant
    data, or irrelevant data, but as long as they fall into the same domain, and fill
    those data into those transformer architectures to build a much large-scale pre-trained
    models.
  topic: technical
- impact_reason: 'Offers a precise, accessible definition of fine-tuning in the context
    of foundation models: adjusting weights for personalization without full retraining.'
  relevance_score: 10
  source: llm_enhanced
  text: Fine-tuning meaning yes, we take the foundation models but we can still take
    the data you have, right? So we can use the data you have to train to fine-tune
    the model, right? It's called fine-tune. It doesn't mean we retrain the whole,
    you know, the foundation model, large language model, etc. We just adjust the
    weights based on the data you have so that it can better be personalized for your
    problems...
  topic: technical
- impact_reason: Provides a clear technical distinction between BERT-like models (encoders,
    focused on representation/embeddings) and generative models.
  relevance_score: 10
  source: llm_enhanced
  text: So the difference is that the previously BERT architecture they use the decoder
    part of the transformer. So you can think it's as a very good representation model.
    So many, it can capture the hidden context among the, in the text between words,
    etc. that where a human sees. So the outcome is some representations or embeddings
    of those text tokens, etc.
  topic: technical
- impact_reason: 'Explains the key technical shift from BERT to GPT-style models:
    leveraging the decoder enables generation, not just representation.'
  relevance_score: 10
  source: llm_enhanced
  text: but now the GPT they also leverage the decoding part of the transformer architecture.
    So meaning they are now able to generate new types of data.
  topic: technical
- impact_reason: Crucial insight into conditional generation in specialized fields
    like chemistry/biology—the ability to generate novel entities while satisfying
    multiple complex, domain-specific constraints.
  relevance_score: 10
  source: llm_enhanced
  text: So now, certainly, it can allow you to generate new sequence, new graphs.
    And really, yeah, additionally, also based on your constraints, your requirements,
    your domain-specific knowledge. So for example, you can generate many different
    types of new molecules, but you can add constraints like have, you know, better
    toxicity, solubility, etc. It can allow you to, you know, do that simultaneously.
  topic: technical/predictions
- impact_reason: Highlights the amplified danger of hallucination in scientific domains
    where outputs (new molecules/genes) cannot be instantly verified by a human, necessitating
    experimental validation.
  relevance_score: 10
  source: llm_enhanced
  text: a way of phenomenon is about hallucination, right? So, when those models,
    AI models, they generate new outputs, they probably seemingly like answers. But
    if you delve into that... But when it goes to the bio-medical, biochemistry, etc.
    For example, it generates a new set of genes, a new molecule, is this something
    that you cannot be answered or validated instantly?
  topic: safety/limitations
- impact_reason: 'Proposes a solution to the validation crisis: creating hybrid evaluation
    metrics that combine domain expertise checks with automated AI metrics to compare
    models effectively.'
  relevance_score: 10
  source: llm_enhanced
  text: So, I think this domain-driven, domain and AI-driven evaluation is key here,
    because there could be so many versions of found data models. Now, if we, you
    know, have those kind of domain plus AI-driven those evaluation metrics, so we
    can score across different models, right?
  topic: safety/strategy
- impact_reason: This highlights the significant gap between investment interest and
    successful, scaled deployment of GenAI in life sciences, a critical business challenge.
  relevance_score: 9
  source: llm_enhanced
  text: Flash forward to 2024, a recent Deloitte survey notes that while 73% of life
    sciences leaders are investing in generative AI initiatives, fewer than 20% have
    successfully scaled these technologies beyond pilot projects.
  topic: business
- impact_reason: 'Articulates the primary value proposition of foundation models:
    enabling performance on tasks with limited proprietary data through transfer learning.'
  relevance_score: 9
  source: llm_enhanced
  text: The benefit is that even if you have very small data for your own machine
    learning tasks, you can leverage those foundation models because they already
    capture some relevant information, although it may not be specifically to your
    data. So that's why they are called foundation models.
  topic: technical
- impact_reason: Provides a concrete example of domain-specific application (life
    sciences) where public data pre-training accelerates research into specific indications.
  relevance_score: 9
  source: llm_enhanced
  text: When we delve into those domain-specific use cases, we probably can better
    understand the benefit of foundation models. So for example, when we study the
    disease pathways and identify new targets for specific indications... But now
    with foundation models, it has a lot of pre-trained models based on publicly available
    molecular data.
  topic: technical
- impact_reason: Connects foundation models directly to the concept of 'digital twins'
    in healthcare, suggesting personalized simulation capabilities based on patient
    data.
  relevance_score: 9
  source: llm_enhanced
  text: The folks, the professionals running the clinical trials can run that foundational
    model based on what they're seeing with this specific patient and that kind of
    acts like the digital twin.
  topic: predictions
- impact_reason: A powerful philosophical statement framing biological data (genetics)
    as language, justifying the application of LLMs to molecular design and drug development.
  relevance_score: 9
  source: llm_enhanced
  text: Genetics are just code, they're just a language so we can build a large language
    model to have kind of the same functionality or be able to test a lot of the,
    you know, genetic functions of a compound as an example to maybe take away some
    of the larger heavy work of meant much of across the drug development process...
  topic: technical
- impact_reason: 'Provides a specific, high-impact R&D application: using GenAI to
    generate synthetic biological data (cell types/expressions) for in-silico testing.'
  relevance_score: 9
  source: llm_enhanced
  text: People have been already applying those models. I just give some examples
    about using foundation models, GenAI to generate new cell types and gene expressions
    so that we can do all kinds of in silico, you know, treatment methods to see,
    to observe the predicted phenotypes, etc.
  topic: technical
- impact_reason: 'Highlights the primary value proposition of using GenAI/Foundation
    Models in early drug discovery: focusing human effort on higher-value targets
    rather than broad screening.'
  relevance_score: 9
  source: llm_enhanced
  text: So that way can allow us to better focus on discovering, you know, novel targets,
    novel gene pathways, etc.
  topic: predictions/business
- impact_reason: Emphasizes the non-negotiable role of domain experts (SMEs) in data
    curation and, critically, in the benchmarking and validation phases of specialized
    foundation models.
  relevance_score: 9
  source: llm_enhanced
  text: But, you know, we still need the domain knowledge people, you know, people
    have those kind of expertise to guide the, you know, the selection of the data
    and also more importantly, then these models are, you build, now how do we benchmark
    with them? So we would definitely need those, the domain experts to be part of
    this model development process.
  topic: strategy/safety
- impact_reason: 'A critical limitation in scientific AI: the pace of data generation
    via physical experiments lags behind the theoretical capabilities of AI architectures.'
  relevance_score: 9
  source: llm_enhanced
  text: But unfortunately, to get those, you know, single-cell RNA-seq data, all those
    kind of more, you know, experiment-driven data, probably we're not exactly there
    yet, because, you know, we still rely on those traditional biotechnology methods
    to collect those data through experiments on cell lines, on human tissues, etc.
    So, there's, you know, where AI, the architecture, the concept there, but the,
    sometimes we are limited by the, you know, experimental side.
  topic: limitations
- impact_reason: Reinforces the necessity of establishing rigorous, objective benchmarks
    rooted in domain knowledge because current AI technology inherently produces uncertainty/hallucinations.
  relevance_score: 9
  source: llm_enhanced
  text: So, I think the ways is that to define those, you know, knowledge-checking
    benchmarks and also have, you know, objective metrics to measure against those
    AI models, because right now the technology cannot give you 100% answers, how
    those nations are always there, right?
  topic: safety
- impact_reason: Describes a strategic shift towards centralized, comprehensive data
    lakes feeding advanced algorithms for broad organizational impact, moving beyond
    simple task automation.
  relevance_score: 8
  source: llm_enhanced
  text: We're seeing a new model where you have a large data repository where everything
    goes, all data is great data. We'll be discriminating about it later, discriminating
    about it later, but from that data repository we can drive more advanced algorithms
    to help with strategic tasks across the entire organization...
  topic: strategy
- impact_reason: Illustrates how foundation models provide 'hints' or background knowledge
    even with limited specific data, enabling hypothesis generation and benchmarking.
  relevance_score: 8
  source: llm_enhanced
  text: You could still look into these foundation models to look at the specific
    gene interactions among specific cell types. You can still get some hints about
    the disease pathways, etc. And then you can benchmark that with the known biological
    knowledge, etc.
  topic: predictions
- impact_reason: Credits the underlying technical breakthrough (the Transformer architecture)
    that enables the current wave of foundation models.
  relevance_score: 8
  source: llm_enhanced
  text: All those models, you know, essentially they have the same, I mean, by nature,
    they have the same setup. So that is based on the breakthrough of the transformer
    architecture that Google proposed a long time ago.
  topic: technical
- impact_reason: Reiterates the power of pre-training on diverse public data sets
    to unlock general capabilities for specialized downstream tasks.
  relevance_score: 8
  source: llm_enhanced
  text: The difference is that we see the benefits of putting a lot of the generic
    public data like text, images into those transformers so we can do, you know,
    so many downstream tasks.
  topic: technical
- impact_reason: 'A core strategic takeaway for building applied AI in complex fields:
    success requires deep, cross-disciplinary teamwork between AI experts and domain
    scientists.'
  relevance_score: 8
  source: llm_enhanced
  text: So, yeah, so it's basically a cross-discipline collaboration, whether in house
    or externally, yeah.
  topic: strategy
- impact_reason: Identifies a structural advantage for language-heavy scientific domains
    (like genetics) in leveraging early GenAI advancements compared to other data
    modalities in life sciences.
  relevance_score: 8
  source: llm_enhanced
  text: it's an advantage that natural language processing as a domain became one
    of the first gigantic generative AI use cases, right? That builds in certain advantage
    to genetics, which is more language-based than anything else versus, you know,
    other domains of health and life sciences, the services involved.
  topic: strategy/predictions
- impact_reason: 'Reiterates the persistent challenge: even with massive pre-training,
    domain-specific models still hinge on access to high-quality, curated data.'
  relevance_score: 8
  source: llm_enhanced
  text: So, so let's talk through the, you know, the challenges, you know, of building
    and deploying those models. So, the first thing is about the data challenge, right?
    So, so the foundation models, although they take all kinds of available data,
    but still they require high-quality data.
  topic: business/technical
- impact_reason: Identifies organizational alignment and communication between technical
    builders (modelers) and end-users/validators (scientists/leadership) as a major
    hurdle for AI adoption.
  relevance_score: 8
  source: llm_enhanced
  text: So, there's a lot of cultural organizational issue. I see the key that really
    we should align, you know, between different parties, like scientists, basic scientists,
    or AI modelers, AI professionals, and also leadership teams, AI adoption, etc.
  topic: business/strategy
- impact_reason: 'Advice for domain experts: they must understand the evolving AI
    landscape (the ''new paradigm'') while recognizing that traditional methods (''the
    old paradigm'') remain relevant, avoiding oversimplification of AI''s role.'
  relevance_score: 8
  source: llm_enhanced
  text: It behooves them [subject matter experts] to kind of have some awareness of
    the new and old paradigm that we were talking about before, how both are still
    present, but how we thought that AI would impact life sciences organization or
    that they'd just be this one school way of doing things is not the case.
  topic: strategy
- impact_reason: Raises a key business/strategy question regarding the build vs. buy
    decision for foundation models in specialized industries.
  relevance_score: 7
  source: llm_enhanced
  text: I'm just curious for these foundational models, is it more often that the
    organizations themselves are developing them or is there a third-party more robust
    market?
  topic: business
- impact_reason: Points out the 'digestibility problem'—even if models are built quickly,
    domain experts must be integrated to interpret and validate their outputs effectively.
  relevance_score: 7
  source: llm_enhanced
  text: how do we digest the models, the capabilities? And again, we have to plug
    in, you know, the right scientists to help us together validate those.
  topic: strategy
source: Unknown Source
summary: '## Comprehensive Summary: Building AI-Ready Cultures in Life Sciences R&D


  This 30-minute podcast episode, featuring **Zhong Liu, Director of Data Science
  in AI at Novartis**, focuses on the paradigm shift in Life Sciences R&D driven by
  **Generative AI (GenAI)** and **Foundation Models (FMs)**, and the cultural and
  technical challenges of scaling these technologies beyond pilot projects.


  ### 1. Focus Area

  The discussion centers on the transition from traditional, task-specific Machine
  Learning (ML) to leveraging large-scale Foundation Models in drug discovery, molecular
  design, and clinical workflows. Key themes include the architectural differences
  between older models (like BERT) and generative FMs (like GPT architectures), the
  necessity of domain-specific fine-tuning, and the organizational hurdles in achieving
  meaningful AI adoption in R&D.


  ### 2. Key Technical Insights

  *   **Paradigm Shift to Foundation Models:** The core technical evolution is moving
  from training models solely on proprietary, labeled data to utilizing massive, pre-trained
  FMs (built on transformer architectures) that capture broad domain knowledge (e.g.,
  human language corpus, public molecular data). This allows for better performance
  even with small, specific datasets through **fine-tuning**.

  *   **Application in Molecular Design:** FMs, leveraging transformer architectures
  applied to chemical representations (like SMILES strings or graphs), can generate
  novel molecules or cell types *in silico*. This generation can be constrained by
  desired properties (e.g., toxicity, solubility), significantly accelerating early
  discovery.

  *   **BERT vs. GPT Architectures:** The shift from models like BERT (decoder-only,
  excellent for representation/embeddings) to GPT-like models (leveraging the decoder
  part) enables the generation of new data sequences (text, code, molecules), moving
  beyond mere prediction to creation.


  ### 3. Business/Investment Angle

  *   **Scaling Challenge:** Despite high investment interest (73% of life sciences
  leaders investing in GenAI), successful scaling beyond pilots remains low (under
  20%), indicating significant implementation friction.

  *   **Data Dependency vs. Model Power:** While FMs offer broad utility, domain-specific
  R&D still faces limitations due to the availability of high-quality, experimental
  data (e.g., single-cell RNA-seq data), highlighting that experimental biotechnology
  advancements must keep pace with AI architecture development.

  *   **ROI Evaluation Difficulty:** Evaluating the Return on Investment (ROI) for
  AI-driven research is complex because generated outputs (e.g., novel molecules)
  cannot be instantly validated, requiring domain-driven evaluation benchmarks against
  known biological knowledge.


  ### 4. Notable Companies/People

  *   **Zhong Liu (Novartis):** The guest, providing insights from a leading pharmaceutical
  company on practical implementation and cultural alignment.

  *   **Google/OpenAI (Implied):** Mention of the transformer architecture breakthrough
  and the capabilities of GPT-like models as the foundation for current GenAI advancements.

  *   **Deloitte:** Cited for a survey highlighting the gap between GenAI investment
  and successful scaling in life sciences.


  ### 5. Future Implications

  The industry is moving toward a hybrid development model, combining leveraging public,
  published FMs with building proprietary, domain-specific versions tailored to internal
  data and needs. Success hinges on **cross-disciplinary collaboration** between AI
  professionals, computer scientists, and domain experts (biologists, chemists) to
  guide data selection, model development, and crucial evaluation processes. The concept
  of using FMs to simulate patient data or genetic code suggests a future where these
  models act as sophisticated **digital twins** for testing hypotheses *in silico*.


  ### 6. Target Audience

  This episode is highly valuable for **Life Sciences R&D leaders, Chief Digital Officers,
  Data Science Directors, and AI Strategy Executives** who are responsible for moving
  GenAI initiatives from experimentation to enterprise-wide deployment and measuring
  their scientific and commercial impact.'
tags:
- artificial-intelligence
- generative-ai
- investment
- ai-infrastructure
- startup
- google
- openai
title: Building AI-Ready Cultures in Life Sciences R&D - with Xiong Liu of Novartis
topics:
- keywords:
  - ai
  - machine learning
  - deep learning
  - neural networks
  - llm
  - large language model
  mentions: 121
  prominence: 1.0
  topic: artificial intelligence
- keywords:
  - generative ai
  - genai
  - chatgpt
  - gpt
  - claude
  - text generation
  - image generation
  mentions: 12
  prominence: 1.0
  topic: generative ai
- keywords:
  - investment
  - funding
  - valuation
  - ipo
  - acquisition
  mentions: 4
  prominence: 0.4
  topic: investment
- keywords:
  - gpu
  - tensor
  - training
  - inference
  - model deployment
  - vector database
  mentions: 1
  prominence: 0.1
  topic: ai infrastructure
- keywords:
  - startup
  - entrepreneur
  - founder
  - venture
  mentions: 1
  prominence: 0.1
  topic: startup
---

<!-- Episode automatically generated from analysis data -->
<!-- Processing completed: 2025-10-21 15:08:40 UTC -->
